Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Medidata Solutions, a provider of SaaS-based clinical development solutions that enhance the efficiency of customers' clinical trials, has reported revenues of $41.1m for the third quarter ended 30 September 2010, an increase of 17%, compared to $35.22m for the same period in 2009.
Subscribe to our email newsletter
Medidata Solutions has posted a net income of $4.66m for the third quarter 2010, or $0.2 per diluted share, compared to net income of $1.55m, or $0.06 per diluted share, for the comparable period in 2009.
Operating income was $6.05m, compared to $2.62m for the comparable period in 2009.
Medidata Solutions has posted a revenue of $119.06m, for the nine months ended 30 September 2010, compared to $102.85m for the year ago period.
For the nine months ended 30 September 2010, Medidata Solutions has posted a net income of $9.49m, or $0.4 per diluted share, compared to $3.44m, or $0.17 per diluted share, for the year ago period.
Operating income was $13.4m, compared to $5.68m for the year ago period.
Medidata chairman and CEO Tarek Sherif said that by continuing to realise their vision of bringing new efficiencies to resource-intensive clinical research processes, they generated another quarter of good customer demand.